Cashion Charles
Insider CIK 1410079 · CNAT SVP, Finance, CFO and Sec. · NBY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-01-26 | 2017-02-01 | 57,500 | — | $0 | 57,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise deriv | 2017-01-09 | 2017-01-11 | 42,424 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise | 2017-01-09 | 2017-01-11 | 42,424 | $0.99 | $42.0K | 42,424 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-02-04 | 2016-02-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-02-04 | 2016-02-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-02-23 | 2015-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2015-01-02 | 2015-01-06 | 69,368 | — | $0 | 377,156 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-02-07 | 2014-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-01-30 | 2014-01-31 | 31,329 | — | $0 | 307,788 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2014-01-02 | 2014-01-09 | 15,000 | — | $0 | 276,459 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 355,352 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion | 2013-07-30 | 2013-08-01 | 43,072 | — | $0 | 149,738 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2013-01-30 | 2013-02-01 | 19,603 | — | $0 | 261,459 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2013-01-02 | 2013-01-15 | 15,000 | — | $0 | 241,856 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2012-01-03 | 2012-01-05 | 68,791 | — | $0 | 68,791 | SEC↗ |